Literature DB >> 12967928

The 'state' of beta-adrenoceptors.

Peter Molenaar1.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12967928      PMCID: PMC1574015          DOI: 10.1038/sj.bjp.0705420

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  10 in total

1.  Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer.

Authors:  Jean-François Mercier; Ali Salahpour; Stéphane Angers; Andreas Breit; Michel Bouvier
Journal:  J Biol Chem       Date:  2002-09-19       Impact factor: 5.157

2.  Anomalous behavior of CGP 12177A on beta 1-adrenergic receptors.

Authors:  M D Pak; P H Fishman
Journal:  J Recept Signal Transduct Res       Date:  1996 Jan-Mar       Impact factor: 2.092

Review 3.  Is there a third heart beta-adrenoceptor?

Authors:  A J Kaumann
Journal:  Trends Pharmacol Sci       Date:  1989-08       Impact factor: 14.819

4.  beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue.

Authors:  A A Konkar; Y Zhai; J G Granneman
Journal:  Mol Pharmacol       Date:  2000-02       Impact factor: 4.436

5.  Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology.

Authors:  A J Kaumann; S Engelhardt; L Hein; P Molenaar; M Lohse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-01       Impact factor: 3.000

6.  (-)-CGP 12177 causes cardiostimulation and binds to cardiac putative beta 4-adrenoceptors in both wild-type and beta 3-adrenoceptor knockout mice.

Authors:  A J Kaumann; F Preitner; D Sarsero; P Molenaar; J P Revelli; J P Giacobino
Journal:  Mol Pharmacol       Date:  1998-04       Impact factor: 4.436

7.  Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.

Authors:  A J Kaumann; P Molenaar
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

8.  Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.

Authors:  B Malinowska; E Schlicker
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

9.  Atypical beta-adrenoceptors, different from beta 3-adrenoceptors and probably from the low-affinity state of beta 1-adrenoceptors, relax the rat isolated mesenteric artery.

Authors:  Hanna Kozłowska; Urszula Szymska; Eberhard Schlicker; Barbara Malinowska
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

10.  Metabolic response to various beta-adrenoceptor agonists in beta3-adrenoceptor knockout mice: evidence for a new beta-adrenergic receptor in brown adipose tissue.

Authors:  F Preitner; P Muzzin; J P Revelli; J Seydoux; J Galitzky; M Berlan; M Lafontan; J P Giacobino
Journal:  Br J Pharmacol       Date:  1998-08       Impact factor: 8.739

  10 in total
  13 in total

1.  The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors.

Authors:  Jillian G Baker
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

2.  Identification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human β1-adrenoceptor.

Authors:  Jillian G Baker; Richard G W Proudman; Stephen J Hill
Journal:  Mol Pharmacol       Date:  2014-03-07       Impact factor: 4.436

Review 3.  Non-traditional roles of G protein-coupled receptors in basic cell biology.

Authors:  Xin Zhang; Ulrike S Eggert
Journal:  Mol Biosyst       Date:  2013-04-05

4.  A study of antagonist affinities for the human histamine H2 receptor.

Authors:  J G Baker
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

5.  A full pharmacological analysis of the three turkey β-adrenoceptors and comparison with the human β-adrenoceptors.

Authors:  Jillian G Baker
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

6.  ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.

Authors:  Nataraj Brahmadevara; Angus M Shaw; Allan MacDonald
Journal:  Br J Pharmacol       Date:  2004-06       Impact factor: 8.739

7.  Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling.

Authors:  Fui Goon Goh; Pei Yuen Ng; Mary Nilsson; Toru Kanke; Robin Plevin
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

8.  The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptor.

Authors:  Jillian G Baker; Richard G W Proudman; Christopher G Tate
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-06       Impact factor: 3.000

Review 9.  Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.

Authors:  Jillian G Baker; Stephen J Hill; Roger J Summers
Journal:  Trends Pharmacol Sci       Date:  2011-03-21       Impact factor: 14.819

10.  Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses.

Authors:  Jillian G Baker; Philip Kemp; Julie March; Laurice Fretwell; Stephen J Hill; Sheila M Gardiner
Journal:  FASEB J       Date:  2011-08-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.